Search research articles
Contact Us
Filters
Showing results (111-120 of 186) with videos related to
Page
of 19
Sort By:
The Journal of Rheumatology
|
August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms
Lisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
Journal of the American Society of Nephrology : JASN
|
April 17, 2009
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
Gerald B Appel, Gabriel Contreras, Mary Anne Dooley, et al.
Plos One
|
June 3, 2016
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
Charis Pericleous, Isabel Ferreira, Orietta Borghi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 4, 2020
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Stéphane Zuily, Hannah Cohen, David Isenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 4, 2009
Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actions
Ian Giles, Charis Pericleous, Xiaowei Liu, et al.
Rheumatology (Oxford, England)
|
October 19, 2017
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index
Kenneth C Kalunian, Murray B Urowitz, David Isenberg, et al.
Arthritis and Rheumatism
|
August 1, 2007
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus
Kathleen McElhone, Janice Abbott, Joanna Shelmerdine, et al.
Arthritis and Rheumatism
|
July 9, 2011
Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
Anastasia Lambrianides, Tabitha Turner-Stokes, Charis Pericleous, et al.
The Journal of Rheumatology
|
September 3, 2010
The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus
Kathleen McElhone, Madhura Castelino, Janice Abbott, et al.
Rheumatology (Oxford, England)
|
June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply
Caroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 186) with videos related to
Sort By:
Page
of 19
The Journal of Rheumatology
|
August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms
Lisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
Journal of the American Society of Nephrology : JASN
|
April 17, 2009
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
Gerald B Appel, Gabriel Contreras, Mary Anne Dooley, et al.
Plos One
|
June 3, 2016
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
Charis Pericleous, Isabel Ferreira, Orietta Borghi, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 4, 2020
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Stéphane Zuily, Hannah Cohen, David Isenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 4, 2009
Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actions
Ian Giles, Charis Pericleous, Xiaowei Liu, et al.
Rheumatology (Oxford, England)
|
October 19, 2017
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index
Kenneth C Kalunian, Murray B Urowitz, David Isenberg, et al.
Arthritis and Rheumatism
|
August 1, 2007
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus
Kathleen McElhone, Janice Abbott, Joanna Shelmerdine, et al.
Arthritis and Rheumatism
|
July 9, 2011
Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
Anastasia Lambrianides, Tabitha Turner-Stokes, Charis Pericleous, et al.
The Journal of Rheumatology
|
September 3, 2010
The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus
Kathleen McElhone, Madhura Castelino, Janice Abbott, et al.
Rheumatology (Oxford, England)
|
June 13, 2018
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply
Caroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, et al.
Page
of 19